R01 CA072038/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2002	1
2003	1
2006	2
2007	1
2009	10
2010	8
2011	7
2012	7
2013	3
2014	4
2015	4
2016	5
2017	3
2018	3
2019	2
2020	2
2021	3
2024	2

1

Dustin D, Gu G, Fuqua SAW. Dustin D, et al. Cancer. 2019 Nov 1;125(21):3714-3728. doi: 10.1002/cncr.32345. Epub 2019 Jul 18. Cancer. 2019. PMID: 31318440 Free PMC article. Review.

2

Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer.

Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SA, Savage MI, Osborne CK, Hilsenbeck SG, Chang JC, Mills GB, Lau CC, Brown PH. Burstein MD, et al. Clin Cancer Res. 2015 Apr 1;21(7):1688-98. doi: 10.1158/1078-0432.CCR-14-0432. Epub 2014 Sep 10. Clin Cancer Res. 2015. PMID: 25208879 Free PMC article.

3

Metastasis: complexity thwarts precision targeting.

Fuqua SAW. Fuqua SAW. Br J Cancer. 2021 Oct;125(8):1033-1035. doi: 10.1038/s41416-021-01401-1. Epub 2021 Jul 5. Br J Cancer. 2021. PMID: 34226682 Free PMC article.

4

Role of MTA2 in human cancer.

Covington KR, Fuqua SA. Covington KR, et al. Cancer Metastasis Rev. 2014 Dec;33(4):921-8. doi: 10.1007/s10555-014-9518-0. Cancer Metastasis Rev. 2014. PMID: 25394532 Free PMC article. Review.

5

The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer.

Pejerrey SM, Dustin D, Kim JA, Gu G, Rechoum Y, Fuqua SAW. Pejerrey SM, et al. Horm Cancer. 2018 Aug;9(4):215-228. doi: 10.1007/s12672-017-0306-5. Epub 2018 May 7. Horm Cancer. 2018. PMID: 29736566 Free PMC article. Review.

6

Hormonal modulation of ESR1 mutant metastasis.

Gu G, Tian L, Herzog SK, Rechoum Y, Gelsomino L, Gao M, Du L, Kim JA, Dustin D, Lo HC, Beyer AR, Edwards DG, Gonzalez T, Tsimelzon A, Huang HJ, Fernandez NM, Grimm SL, Hilsenbeck SG, Liu D, Xu J, Alaniz A, Li S, Mills GB, Janku F, Kittler R, Zhang XH, Coarfa C, Foulds CE, Symmans WF, Andò S, Fuqua SAW. Gu G, et al. Oncogene. 2021 Feb;40(5):997-1011. doi: 10.1038/s41388-020-01563-x. Epub 2020 Dec 15. Oncogene. 2021. PMID: 33323970 Free PMC article.

7

Estrogen receptor mutations and changes in downstream gene expression and signaling.

Barone I, Brusco L, Fuqua SA. Barone I, et al. Clin Cancer Res. 2010 May 15;16(10):2702-8. doi: 10.1158/1078-0432.CCR-09-1753. Epub 2010 Apr 28. Clin Cancer Res. 2010. PMID: 20427689 Free PMC article. Review.

8

Metabolomic Rewiring Promotes Endocrine Therapy Resistance in Breast Cancer.

Ahn S, Park JH, Grimm SL, Piyarathna DWB, Samanta T, Putluri V, Mezquita D, Fuqua SAW, Putluri N, Coarfa C, Kaipparettu BA. Ahn S, et al. Cancer Res. 2024 Jan 16;84(2):291-304. doi: 10.1158/0008-5472.CAN-23-0184. Cancer Res. 2024. PMID: 37906431

9

Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sight.

Fuqua SA, Gu G, Rechoum Y. Fuqua SA, et al. Breast Cancer Res Treat. 2014 Feb;144(1):11-9. doi: 10.1007/s10549-014-2847-4. Epub 2014 Feb 1. Breast Cancer Res Treat. 2014. PMID: 24487689 Free PMC article. Review.

10

Transcriptomic landscape of breast cancers through mRNA sequencing.

Eswaran J, Cyanam D, Mudvari P, Reddy SD, Pakala SB, Nair SS, Florea L, Fuqua SA, Godbole S, Kumar R. Eswaran J, et al. Sci Rep. 2012;2:264. doi: 10.1038/srep00264. Epub 2012 Feb 14. Sci Rep. 2012. PMID: 22355776 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

57 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year